Quantification of telomerase activity in normal oral mucosal tissue and oral squamous cell carcinoma.
OBJECTIVE
The role of telomeres and telomerase in oral cancer is an area of much recent interest. The understanding of the role of telomere biology, the end replication problem leading to genomic instability and the reactivation of telomerase, is absolutely critical to our understanding of oral cancer, and more so, to our ability of early diagnosis and developing novel therapies and cancer prevention approaches. The aim of the present study was to quantify telomerase activity (TA) in oral squamous cell carcinoma (OSCC) and normal oral mucosa and assess the role of telomerase as diagnostic and prognostic marker of oral malignancy.


METHODS
We quantified TA in 45 patients with OSCC and 20 normal oral mucosal specimens using polymerase chain reaction-based telomeric repeat amplification protocol assay and compared it with the clinical status and grade of malignancy.


RESULTS
TA was detected in 89% of malignant and 5% of normal oral mucosal tissue. The TA levels ranged from 0.28 to 6.91 (mean 2.05, standard deviation [SD] 1.33) in OSCC and 0.21 to 1.09 (mean 0.54, SD 0.27) in normal oral mucosa. There was no relationship between TA levels and clinical stages, site of the lesion, history of adverse habits, or sex of the patient. However, under the WHO classification, there were significant differences (P < 0.00) between Grades I, II, and III. Furthermore, increasing age of the patient significantly correlated with TA.


CONCLUSIONS
The results of the present study indicate that activation of TA is frequent in OSCC. Statistically significant difference in quantified telomerase levels of OSCC and normal oral mucosa (P < 0.00) demonstrates the significant clinical usefulness of telomerase activation as a valuable marker for diagnosis while significant correlation of TA with grades of malignancy indicates its effectiveness as marker for prognosis of OSCC.
Department of Oral Medicine and Radiology, Faculty of Dentistry, Jamia Millia Islamia, New Delhi, India.
Arpita
A
Rai
Department of Oral Medicine and Radiology, S.D.M. College of Dental Sciences and Hospital, Dharwad, Karnataka, India.
Venkatesh G
VG
Naikmasur
Department of Oral Medicine and Radiology, SDM College of Dental Sciences, Dharwad, Karnataka, India.
Atul
A
Sattur
Biomarker; squamous cell carcinoma; telomerase; telomere
Int J Oral Maxillofac Surg. 2004 Oct;33(7):693-9
15337184
Oral Oncol. 1999 May;35(3):283-9
10621849
Arch Otolaryngol Head Neck Surg. 1998 Jul;124(7):784-8
9677114
J Oral Pathol Med. 1999 Oct;28(9):389-96
10535361
Head Neck. 2002 Dec;24(12):1060-7
12454944
Oral Oncol. 2004 Mar;40(3):314-20
14747063
J Oral Pathol Med. 1998 Mar;27(3):111-5
9563802
Curr Opin Genet Dev. 1995 Apr;5(2):249-55
7613096
Acta Otolaryngol. 1998 Jun;118(3):423-7
9655221
Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10114-8
1438199
Oral Oncol. 2000 Jul;36(4):347-52
10899673
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9082-6
7568077
Cancer Res. 1996 Dec 15;56(24):5720-2
8971181
J Can Dent Assoc. 2002 Nov;68(10):617-21
12410942
Science. 1994 Dec 23;266(5193):2011-5
7605428
Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2003 May;17(5):285-7
12916358
J Oral Pathol Med. 2004 Oct;33(9):538-42
15357674
J Invest Dermatol. 1998 Dec;111(6):1045-52
9856815
Oral Oncol. 2003 Sep;39(6):580-8
12798401
Clin Cancer Res. 2001 Oct;7(10):3079-86
11595698
Cancer Lett. 2003 May 15;194(2):221-33
12757980
Cancer Res. 1996 Dec 15;56(24):5600-4
8971162
J Invest Dermatol. 1992 Oct;99(4):422-30
1402000
J Clin Oncol. 2000 Jul;18(13):2626-34
10893296
Eur J Cancer. 1997 Apr;33(5):750-60
9282113
Oral Oncol. 1999 Sep;35(5):510-5
10694952
Cancer Epidemiol Biomarkers Prev. 1997 Jun;6(6):413-20
9184774